A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID

Doxorubicin is a widely used anthracycline-based anti-tumor agent for both solid and liquid tumors. Mounting evidence has demonstrated that microRNAs (miRNAs) are involved in chemoresistance and tumorigenesis. However, the roles of microRNA-501-5p (miR-501) in doxorubicin resistance and gastric canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yun-chao, Liu, Xu, Li, Min, Li, Yan, Li, Chun-yan, Lu, Ying, Sanches, Jaceline, Wang, Lu, Du, Yue, Mao, Li-min, Zuo, Si-bo, Liu, Hui-ting, Shen, Jie, Wang, Bo, Hou, Li, Li, Lian-hong, Tang, Jian-wu, Ju, Jing-fang, Guan, Hong-wei, Song, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077131/
https://www.ncbi.nlm.nih.gov/pubmed/30195794
http://dx.doi.org/10.1016/j.omtn.2018.06.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077131/
https://www.ncbi.nlm.nih.gov/pubmed/30195794
http://dx.doi.org/10.1016/j.omtn.2018.06.011

Ejemplares similares